Opus Genetics, Inc.
IRD
$2.04
$0.052.51%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -150.82% | -313.15% | -418.72% | -476.13% | -194.58% |
| Total Depreciation and Amortization | 1,566.67% | 825.00% | 360.00% | 66.67% | -25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,005.36% | 510.16% | 451.69% | 502.17% | -28.67% |
| Change in Net Operating Assets | -107.91% | 95.65% | -23.97% | -24.19% | 201.26% |
| Cash from Operations | -141.78% | -177.68% | -806.79% | -2,200.00% | -158.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 40.63% | -48.49% | -28.32% | -51.42% | 50.89% |
| Repurchase of Common Stock | -73.81% | -73.81% | -73.81% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3,806.98% | 3,940.44% | 4,210.91% | 16.55% | -203.39% |
| Cash from Financing | 228.14% | 67.82% | 96.17% | -53.38% | 46.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.73% | -727.09% | -165.69% | -356.51% | -120.07% |